GLP1s and Hashimotos 🤝🤝🤝 #hashimotos #hashimotosthyroiditis #hashimotosdisease #glps #glp1 i

In this clinical commentary, McCall McPherson of Modern Thyroid Clinic explains how GLP‑1 medications can dramatically improve outcomes for patients with Hashimoto's thyroiditis, especially those who have exhausted lifestyle interventions. He reports that GLP‑1 agents reduce systemic inflammation within about 48 hours, quickly lowering the high inflammatory burden typical of Hashimoto's. Over longer periods, patients show consistent reductions in thyroid‑specific antibodies when measured every three months, even without additional lifestyle changes. These immunologic improvements are accompanied by better blood‑sugar regulation, more effective thyroid hormone activity, and overall symptom relief. McPherson emphasizes that Modern Thyroid Clinic has amassed what he believes to be the world’s largest dataset of thyroid patients on GLP‑1 therapy, providing ongoing, real‑world evidence of these benefits.










